drugset / Trial / NCT03339635

Short-term Testosterone Replacement in Testicular Cancer Survivors

NCT03339635

Phase 2 Completed 32 enrolled University Medical Center Groningen
RandomizedParallel-groupDouble-blindPrevention

Summary

To assess the effects of testosterone replacement therapy on fat mass and other components of the metabolic syndrome. A randomized double-blind placebo controlled intervention study, followed by an open-label treatment phase. Results of this pilot study will be used to design a multicenter randomized controlled study in a large group of TC survivors

Timeline

Start
2018-12-21
Primary completion
2024-06-26
Completion
2024-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 50 mg Other

Indications